2024-10-23 01:50:10
Harbour BioMed to Present the Latest Progress of Next-Generation Anti-CTLA-4 Antibody HBM4003 at 2022 ASCO Annual Meeting
Corporate/ 2023-07-24
Harbour BioMed to Present the Latest Pro...

CAMBRIDGE,Mass. and ROTTERDAM,Netherlands and SUZHOU,China,May 10,2022-- Harbour BioMed (the "Company",HKEX: 02142),a global bioph...

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets
Health/ 2023-07-22
Bora Pharmaceuticals acquires Eden Biolo...

Bora establishes a leadership position in Taiwan\'s CDMO sector as it continues to expand into the global CDMO market

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release